Skip to main content
Fig. 5 | Journal of Experimental & Clinical Cancer Research

Fig. 5

From: Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis

Fig. 5

Phospho-EGFR binds to Arf1 in HNSCC cells. a The EGFR-Arf1 binding in HN12 cells determined by IP. Preimmune IgG was used as a negative control. b The effect of erlotinib on Arf1 activation determined by Western blotting. c The effect of 5 μM erlotinib on the engagement of Arf1 in the EGFR immunocomplex determined by IP

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us